Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) shares dropped 8.8% during trading on Tuesday . The company traded as low as $79.97 and last traded at $80.21. Approximately 82,870 shares were traded during trading, a decline of 47% from the average daily volume of 156,157 shares. The stock had previously closed at $87.91. Analysts […]
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) insider Matthew E. Korenberg sold 3,440 shares of Ligand Pharmaceuticals stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $84.54, for a total value of $290,817.60. Following the sale, the insider now directly owns 100,421 shares in […]
Ligand Pharmaceuticals (NASDAQ:LGND) Trading Up 7.3% on Strong Earnings tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Ligand Pharmaceuticals (NASDAQ:LGND) Stock Rating Reaffirmed by Benchmark themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) have received an average rating of “Buy” from the four brokerages that are covering the stock, MarketBeat reports. Four investment analysts have rated the stock with a buy rating. The average twelve-month price objective among brokers that have issued a report on the stock in […]